Informação sobre produto
JHU37152 is a potent cyclin-dependent kinase (CDK) inhibitor that has shown promise in the treatment of leukemia and other types of cancer. It is an analog of a natural compound found in Chinese medicinal plants and has been shown to inhibit the growth of human cancer cells by inducing apoptosis, or programmed cell death. JHU37152 specifically targets CDKs, which are enzymes that regulate the cell cycle and are often overexpressed in tumor cells. By inhibiting CDK activity, this compound can halt the progression of cancer cells and prevent them from dividing. JHU37152 is a promising new class of anti-cancer drugs that may have significant therapeutic potential for treating a variety of cancer types.
Propriedades químicas
Consulta técnica sobre: 3D-UUD97967 JHU37152
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
